A 38-year-old woman with a 3-year history of hypothyroidism on levothyroxine 75 mcg daily presents with persistent fatigue, myalgia, and weight gain despite TSH normalization (1.2 mIU/L; normal 0.5–5.0). Free T₄ is 1.0 ng/dL (normal 0.8–1.8) and free T₃ is 2.1 pg/mL (normal 2.3–4.2). She reports poor absorption of oral medications due to celiac disease diagnosed 6 months ago. What is the most appropriate next step?

Explanation

## Clinical Context **Key Point:** This patient has biochemical euthyroidism (normal TSH) but persistent hypothyroid symptoms. The critical clue is **celiac disease diagnosed 6 months ago**, which impairs small-bowel absorption of levothyroxine. ## Pathophysiology of Malabsorption Celiac disease causes villous atrophy and mucosal inflammation, reducing the absorptive surface area for levothyroxine (a lipophilic drug absorbed in the proximal small intestine). Even on adequate levothyroxine doses, serum levels may remain suboptimal if intestinal healing is incomplete. ## Diagnostic Interpretation | Parameter | Value | Interpretation | |-----------|-------|----------------| | TSH | 1.2 mIU/L | Normal | | Free T₄ | 1.0 ng/dL | Low-normal | | Free T₃ | 2.1 pg/mL | **Low** (normal >2.3) | | Clinical status | Persistent symptoms | Suggests inadequate peripheral T₃ | **High-Yield:** The combination of normal TSH with **low free T₃** in the setting of malabsorption indicates that the patient is not receiving adequate levothyroxine bioavailability, despite a "normal" TSH. TSH alone is insufficient in malabsorption states. ## Management Algorithm ```mermaid flowchart TD A[Hypothyroid symptoms + Normal TSH]:::outcome --> B{Malabsorption present?}:::decision B -->|Yes| C[Optimize GI absorption]:::action C --> D[Ensure gluten-free diet<br/>compliance]:::action D --> E[Consider liquid or<br/>sublingual levothyroxine]:::action E --> F[Separate from interfering<br/>drugs/foods]:::action F --> G[Recheck TSH + free T3<br/>in 6-8 weeks]:::action B -->|No| H[Add T3 or increase T4]:::action ``` ## Rationale for Correct Answer **Clinical Pearl:** In malabsorption-related hypothyroidism, the first step is to **maximize absorption** before escalating doses or adding agents. This includes: 1. **Strict gluten-free diet:** Allows intestinal healing; may take 6–12 months for complete mucosal recovery 2. **Optimize levothyroxine administration:** - Take on an empty stomach (30–60 min before breakfast) - Separate from calcium, iron, PPIs, and other interfering agents 3. **Liquid or sublingual levothyroxine:** Better bioavailability than tablets in malabsorption 4. **Recheck free T₃ and TSH** after 6–8 weeks of optimized absorption **Warning:** Simply increasing the levothyroxine dose (option B) will not improve absorption if the underlying intestinal pathology persists. Similarly, adding T₃ (option C) bypasses the root cause. ## Why Other Options Are Incorrect | Option | Why Wrong | |--------|----------| | IM levothyroxine weekly | Bypasses the absorption problem but is not standard first-line; reserved for severe malabsorption or non-compliance after oral optimization fails | | Increase to 100 mcg daily | Does not address the underlying malabsorption; higher doses will not improve bioavailability if intestinal healing is incomplete | | Add liothyronine 12.5 mcg BID | Adds complexity and cost; does not treat the root cause (poor levothyroxine absorption); may cause T₃ toxicity | **Mnemonic:** **GLUTEN-FREE-FIRST** — In celiac disease with hypothyroidism, optimize diet and absorption before escalating or adding thyroid agents.